Related Experiment Videos
Aspects of chronopharmacology and chronotherapy in pediatrics
Insights
Pediatric chronopharmacology research is limited, lacking data on infants and infradian rhythms. Timing medication administration can improve therapeutic outcomes and reduce side effects in children.
Area of Science:
- Pediatric Chronopharmacology
- Circadian Rhythms
- Pharmacokinetics
Background:
- Current pediatric chronopharmacology research primarily focuses on children aged 6-15 years.
- Data on chronopharmacological changes in newborns and infants is scarce.
- Infradian rhythms (biological cycles of about one year) have not been explored in older children.
Purpose of the Study:
- To highlight the limitations in current pediatric chronopharmacological research.
- To emphasize the potential benefits of incorporating chronopharmacological principles into pediatric medicine.
- To underscore the need for further research into chronopharmacology across a wider pediatric age range.
Main Methods:
- Review of existing pediatric chronopharmacological findings.
- Identification of documented biologic time-related changes for specific medications (phenytoin, theophylline, orciprenaline, corticosteroids, anticancer agents).
- Analysis of the impact of timing on drug pharmacokinetics, effectiveness, and side effects.
Main Results:
- Existing pediatric chronopharmacological data is limited to specific age groups and circadian rhythms.
- Biologic time-related changes are documented for several drug classes, affecting pharmacokinetics and efficacy.
- Chronopharmacological approaches offer greater precision in studies compared to conventional methods.
Conclusions:
- Chronopharmacology holds significant potential for improving pediatric therapeutics.
- Appropriate timing of medication administration can enhance desired effects and minimize adverse events in children.
- Further research is needed to expand chronopharmacological understanding across all pediatric age groups and explore various bioperiodicities.
Abstract:
Pediatric chronopharmacological findings until now have been limited to circadian changes in children from ages 6 to 15 years. This means that data in newborns and even in infants of 1 year are not available and other bioperiodicities with periods of about-1-year (infradian rhythms) have not been explored in older children. Biologic time-related changes have been documented for phenytoin and theophylline with regard to pharmacokinetics, for orciprenaline with regard to bronchodilation, and for corticosteroids as well as anticancer agents with regard to their effectiveness. Despite the limited number of experiments performed to date, it is already possible to state that a chronopharmacological approach provides better precision in pharmacologic study than the conventional approach not using time-related data and better therapeutics can be achieved with the help of chronopharmacological facts since appropriate timing in administration of medicine usually enhances its desired and/or reduces its undesired effects.